Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear distribution protein nudE-like 1 (NDEL1) is a conserved scaffold protein encoded by the NDEL1 gene in humans, essential for intracellular transport and cell division[1]. It primarily regulates the dynein motor complex by binding both dynein and its cofactor LIS1, thereby facilitating microtubule-based vesicular and organelle transport and supporting proper mitotic spindle positioning. NDEL1 is highly expressed in the brain, where it orchestrates neuronal precursor proliferation, migration, and maturation—key processes during neurodevelopment[2][3][5]. Phosphorylation of NDEL1 by kinases such as DYRK2 and GSK3β modulates its function in neuronal morphogenesis and cytoskeletal dynamics[2]. Loss of NDEL1 function in animal models leads to embryonic lethality and severe neurodevelopmental defects, implicating it in human neurodevelopmental and neuropsychiatric disorders including schizophrenia[2][3]. Although NDEL1 is not a conventional therapeutic target like a receptor or enzyme, it is functionally critical for nervous system development and its disruption is associated with disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear distribution protein nudE-like 1 (NDEL1).